Canonical Question
Antihypertensive
Master answer
Angiotensinogen
- Cleaved by renin
- release from juxtaglomerular cells:
- Lowered renal arterial pressure
- Less NaCl (more about Cl–) past macula densa
- Sympathetic nervous system activation
Angiotensin I
- Converted by ACE to Angiotensin II
Angiotensin II
- Actions: Via AT1 receptors (AT2 receptors have unclear significance)
- Renal:
- Afferent and renal artery vasoconstriction (weaker)
- Efferent vasoconstriction (stronger)
- Constricts mesangial cells (decrease GFR)
- Increased sodium and water resorption
- -> Na+/H+ antiporter
- -> Decreased hydrostatic pressure in capillary (Starling force)
- Vascular:
- Widespread vaso and veno constriction
- Promotes hyperplasia
- Cardiac
- Promotes hyperplasia
- Neural:
- Directly increases noradrenaline release from presynaptic membrane
- Stimulates catecholamine release
- Promotes aldosterone release
- Degrades bradykinin
- So less NO, cAMP -> less vasodilation
Aldosterone
- Increases activity of Na+/H+ antiporter, Na+/K+ ATPase in the distal convoluted tubule and collecting duct -> water retention
- There is also an ACE independent pathway to angiotensin II formation
ACE inhibitors:
- Block ACE
- Reduce afterload
- Modulate cardiac sympathetic stimulation
- Inhibit cardiac and vascular hypertrophy
- Cause cardiac remodelling
A2RB:
- Block AT1 receptors
Mooney 2016
Further Reading:
Exam appearances
| Exam | Exact wording | Relationship | Success |
|---|---|---|---|
| 2008B Q21 | Outline the pathophysiological basis for the use of angiotensin converting enzyme inhibitors (ACE-I) and angiotensin receptor blockers (ARB) in congestive cardiac failure. | historical_member | — |